rs121908404

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePS3PM2PP5_Moderate

The NM_021102.4(SPINT2):​c.1A>G​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000217 in 1,381,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). ClinVar reports functional evidence for this variant: "SCV005700626: Studies have shown that disruption of the initiator codon alters SPINT2 gene expression (PMID:19185281).".

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000022 ( 0 hom. )

Consequence

SPINT2
NM_021102.4 start_lost

Scores

6
2
7

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 1.37

Publications

5 publications found
Variant links:
Genes affected
SPINT2 (HGNC:11247): (serine peptidase inhibitor, Kunitz type 2) This gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor. This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
SPINT2 Gene-Disease associations (from GenCC):
  • syndromic congenital sodium diarrhea
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • congenital secretory sodium diarrhea 3
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 3 pathogenic variants. Next in-frame start position is after 51 codons. Genomic position: 38283671. Lost 0.199 part of the original CDS.
PS3
PS3 evidence extracted from ClinVar submissions: SCV005700626: Studies have shown that disruption of the initiator codon alters SPINT2 gene expression (PMID: 19185281).
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-38264893-A-G is Pathogenic according to our data. Variant chr19-38264893-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 3611761.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021102.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPINT2
NM_021102.4
MANE Select
c.1A>Gp.Met1?
start_lost
Exon 1 of 7NP_066925.1O43291-1
SPINT2
NM_001166103.2
c.1A>Gp.Met1?
start_lost
Exon 1 of 6NP_001159575.1O43291-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPINT2
ENST00000301244.12
TSL:1 MANE Select
c.1A>Gp.Met1?
start_lost
Exon 1 of 7ENSP00000301244.5O43291-1
SPINT2
ENST00000454580.7
TSL:1
c.1A>Gp.Met1?
start_lost
Exon 1 of 6ENSP00000389788.2O43291-2
SPINT2
ENST00000902579.1
c.1A>Gp.Met1?
start_lost
Exon 1 of 7ENSP00000572638.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000217
AC:
3
AN:
1381980
Hom.:
0
Cov.:
31
AF XY:
0.00000440
AC XY:
3
AN XY:
681982
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31436
American (AMR)
AF:
0.00
AC:
0
AN:
35620
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25104
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79064
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35474
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4292
European-Non Finnish (NFE)
AF:
0.00000186
AC:
2
AN:
1077676
Other (OTH)
AF:
0.00
AC:
0
AN:
57636
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.19
CADD
Benign
20
DANN
Benign
0.96
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.84
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Benign
-0.81
T
PhyloP100
1.4
PROVEAN
Benign
-0.75
N
REVEL
Uncertain
0.31
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.062
B
Vest4
0.89
MutPred
0.99
Gain of catalytic residue at M1 (P = 0.025)
MVP
0.64
ClinPred
0.99
D
GERP RS
3.6
PromoterAI
-0.32
Neutral
Varity_R
0.91
gMVP
0.86
Mutation Taster
=4/196
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908404; hg19: chr19-38755533; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.